When: Tue, Mar 15, 2022 10:00 AM – 11:00 AM (MDT)
Breast cancer screenings may seem straightforward, but in the world of quality reporting, it’s not always as easy as it appears on the surface. This is reflected in the nationwide results of only 45% of qualifying patients receiving this essential screening. There are many exclusions for this measure that have been expanded in 2022. We’ll review coding for history of conditions and break our coding down to review screenings vs. biopsies vs. other procedures. We’ll also explore programs that may be available to help patients pay for mammograms or receive them at a reduced rate.